je.st
news
Home
› Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases
Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases
2013-10-01 23:09:48| Chemicals - Topix.net
Initial targets are dry age-related macular degeneration , glaucoma and retinitis pigmentosa.
Tags: form
class
sun
develop
Category:Chemicals